Who has invested in Passage Bio?

No investors are named on the public record for Passage Bio yet.

Passage Bio Funding: $442M Raised, Growth (2020)

Passage Bio funding overview

Passage Bio is a Biotech company based in Philadelphia. Passage Bio has raised $442M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in January 2020. The round record for Passage Bio runs through 2020; nothing later has been disclosed.

Passage Bio at a glance

Total raised: $442M
Latest round: Growth
Latest round date: January 2020
Industry: Biotech
Headquarters: Philadelphia

Frequently asked about Passage Bio funding

How much has Passage Bio raised?: Passage Bio has raised $442M in total disclosed funding across the rounds on record.
Who has invested in Passage Bio?: No investors are named on the public record for Passage Bio yet.
What was the latest Passage Bio funding round?: The most recent disclosed round is a Growth, announced in January 2020.
Where is Passage Bio based?: Passage Bio is based in Philadelphia.
What sector does Passage Bio operate in?: Passage Bio is tracked under Biotech from Philadelphia, with $442M in disclosed funding.
When did Passage Bio last raise?: The last disclosed Passage Bio round closed in January 2020 at Growth.

Every Passage Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Philadelphia at a similar stage.

Passage Bio Funding: $442M Raised, Growth (2020)

Passage Bio funding overview

Passage Bio at a glance

Frequently asked about Passage Bio funding

Companies related to Passage Bio (36)

Browse related funding lists (3)